DK0416951T3 - Lægemidler indeholdende salmeterol og fluticason - Google Patents
Lægemidler indeholdende salmeterol og fluticasonInfo
- Publication number
- DK0416951T3 DK0416951T3 DK90309846.5T DK90309846T DK0416951T3 DK 0416951 T3 DK0416951 T3 DK 0416951T3 DK 90309846 T DK90309846 T DK 90309846T DK 0416951 T3 DK0416951 T3 DK 0416951T3
- Authority
- DK
- Denmark
- Prior art keywords
- fluticasone
- medicines containing
- salmeterol
- containing salmeterol
- inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898920392A GB8920392D0 (en) | 1989-09-08 | 1989-09-08 | Medicaments |
GB898923644A GB8923644D0 (en) | 1989-10-20 | 1989-10-20 | Medicaments |
SG166294A SG166294G (en) | 1989-09-08 | 1994-11-18 | Inhalation medicaments for treating respiratory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0416951T3 true DK0416951T3 (da) | 1994-02-14 |
Family
ID=27264677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90309846.5T DK0416951T3 (da) | 1989-09-08 | 1990-09-07 | Lægemidler indeholdende salmeterol og fluticason |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0416951B1 (da) |
JP (1) | JP3042867B2 (da) |
AT (1) | ATE99941T1 (da) |
BE (1) | BE1003053A3 (da) |
CA (1) | CA2024916C (da) |
CH (1) | CH680983C9 (da) |
DE (2) | DE69005951T2 (da) |
DK (1) | DK0416951T3 (da) |
ES (1) | ES2062392T3 (da) |
FR (1) | FR2651677B1 (da) |
HK (1) | HK18695A (da) |
HU (1) | HU211272A9 (da) |
IE (1) | IE65535B1 (da) |
IL (1) | IL95590A (da) |
IT (1) | IT1241996B (da) |
LU (1) | LU90392I2 (da) |
NL (1) | NL990012I2 (da) |
NZ (1) | NZ235221A (da) |
PH (1) | PH27594A (da) |
SG (1) | SG166294G (da) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
JP3342484B2 (ja) * | 1991-12-18 | 2002-11-11 | アストラ・アクチエボラーグ | 新規な配合 |
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
EP1862164A3 (de) | 1998-11-13 | 2012-12-26 | Jagotec AG | Trockenpulver zur Inhalation |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
EP1143930B8 (en) | 1999-09-11 | 2008-03-19 | Glaxo Group Limited | Pharmaceutical formulation of fluticasone propionate |
AU2206801A (en) * | 1999-12-24 | 2001-07-09 | Alan Leslie Cripps | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
EP1305329B2 (en) | 2000-08-05 | 2015-03-18 | Glaxo Group Limited | 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
ATE365720T1 (de) | 2001-03-08 | 2007-07-15 | Glaxo Group Ltd | Agonisten von beta-adrenorezeptoren |
ATE381537T1 (de) | 2001-03-22 | 2008-01-15 | Glaxo Group Ltd | Formanilid-derivative als beta2-adrenorezeptor- agonisten |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
BR0209271A (pt) | 2001-04-30 | 2004-06-15 | Glaxo Group Ltd | Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto |
SI1425001T1 (sl) | 2001-09-14 | 2009-04-30 | Glaxo Group Ltd Glaxo Welcome | Fenetanolaminski derivati za zdravljenje respiratornih bolezni |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
EP1757281A3 (en) * | 2002-02-04 | 2009-07-15 | Glaxo Group Limited | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
WO2003066033A1 (en) † | 2002-02-04 | 2003-08-14 | Glaxo Group Limited | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
CA2477714C (en) * | 2002-03-04 | 2011-01-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament |
GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
DE60323138D1 (de) | 2002-12-12 | 2008-10-02 | Nycomed Gmbh | Kombinationsarzneimittel aus r,r-formoterol und ciclesonide |
GB0303396D0 (en) | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
SE527069C2 (sv) | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
US20070071689A1 (en) | 2003-08-06 | 2007-03-29 | Galephar M/F | Advantageous combination for inhalation of nacystelyn and bronchodilators |
JP2007528889A (ja) * | 2004-03-12 | 2007-10-18 | シプラ・リミテッド | 吸入製剤 |
SI1616592T1 (sl) | 2004-07-16 | 2011-03-31 | Almirall Sa | Inhalator za uporabo farmacevtskih snovi v prahu in vloĹľek za prah za uporabo s tem inhalatorjem |
CA2673553C (en) | 2006-12-22 | 2014-06-17 | Laboratorios Almirall, S.A. | Breath actuated metering slide for a powder inhaler |
CN101744792B (zh) * | 2008-12-17 | 2013-04-17 | 张凯 | 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺 |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
US9463161B2 (en) | 2009-05-29 | 2016-10-11 | Pearl Therapeutics, Inc. | Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems |
JP6454323B2 (ja) | 2013-03-15 | 2019-01-16 | パール セラピューティクス,インコーポレイテッド | 粒子状結晶性材料のコンディショニングのための方法及びシステム |
EP2991625A1 (en) * | 2013-04-29 | 2016-03-09 | Sanofi SA | Inhalable pharmaceutical compositions and the inhaler devices containing them |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2107715B (en) * | 1981-10-19 | 1985-11-13 | Glaxo Group Ltd | Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it |
ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
FR2588474B1 (fr) * | 1985-10-16 | 1987-11-27 | Cird | Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste |
-
1990
- 1990-09-05 IL IL9559090A patent/IL95590A/en not_active IP Right Cessation
- 1990-09-07 JP JP2235997A patent/JP3042867B2/ja not_active Expired - Lifetime
- 1990-09-07 IE IE325690A patent/IE65535B1/en not_active IP Right Cessation
- 1990-09-07 CA CA002024916A patent/CA2024916C/en not_active Expired - Lifetime
- 1990-09-07 AT AT90309846T patent/ATE99941T1/de active
- 1990-09-07 DK DK90309846.5T patent/DK0416951T3/da active
- 1990-09-07 DE DE69005951T patent/DE69005951T2/de not_active Expired - Lifetime
- 1990-09-07 PH PH41153A patent/PH27594A/en unknown
- 1990-09-07 ES ES90309846T patent/ES2062392T3/es not_active Expired - Lifetime
- 1990-09-07 IT IT48260A patent/IT1241996B/it active Protection Beyond IP Right Term
- 1990-09-07 BE BE9000862A patent/BE1003053A3/fr not_active IP Right Cessation
- 1990-09-07 DE DE1990605951 patent/DE19975040I2/de active Active
- 1990-09-07 CH CH2906/90A patent/CH680983C9/de not_active IP Right Cessation
- 1990-09-07 EP EP90309846A patent/EP0416951B1/en not_active Expired - Lifetime
- 1990-09-07 NZ NZ235221A patent/NZ235221A/en unknown
- 1990-09-07 FR FR909011142A patent/FR2651677B1/fr not_active Expired - Lifetime
-
1994
- 1994-11-18 SG SG166294A patent/SG166294G/en unknown
-
1995
- 1995-02-09 HK HK18695A patent/HK18695A/xx not_active IP Right Cessation
- 1995-06-02 HU HU95P/P00150P patent/HU211272A9/hu unknown
-
1999
- 1999-04-14 NL NL990012C patent/NL990012I2/nl unknown
- 1999-04-26 LU LU90392C patent/LU90392I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2062392T3 (es) | 1994-12-16 |
IT9048260A1 (it) | 1992-03-07 |
HU211272A9 (en) | 1995-11-28 |
FR2651677A1 (fr) | 1991-03-15 |
EP0416951B1 (en) | 1994-01-12 |
DE69005951D1 (de) | 1994-02-24 |
PH27594A (en) | 1993-08-31 |
NZ235221A (en) | 1992-11-25 |
LU90392I2 (fr) | 1999-06-28 |
DE69005951T2 (de) | 1994-05-26 |
CA2024916A1 (en) | 1991-03-09 |
IL95590A0 (en) | 1991-09-16 |
NL990012I1 (nl) | 1999-07-01 |
IE65535B1 (en) | 1995-11-01 |
JP3042867B2 (ja) | 2000-05-22 |
BE1003053A3 (fr) | 1991-11-05 |
IL95590A (en) | 1996-06-18 |
NL990012I2 (nl) | 1999-09-01 |
EP0416951A1 (en) | 1991-03-13 |
ATE99941T1 (de) | 1994-01-15 |
IT9048260A0 (it) | 1990-09-07 |
CH680983C9 (da) | 2008-08-15 |
HK18695A (en) | 1995-02-17 |
CH680983C1 (da) | 2008-06-25 |
FR2651677B1 (fr) | 1993-08-06 |
CH680983A5 (da) | 1992-12-31 |
IE903256A1 (en) | 1991-03-13 |
CA2024916C (en) | 2002-07-09 |
DE19975040I2 (de) | 2006-07-13 |
IT1241996B (it) | 1994-02-02 |
JPH03167120A (ja) | 1991-07-19 |
SG166294G (en) | 1995-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0416951T3 (da) | Lægemidler indeholdende salmeterol og fluticason | |
DE69002718D1 (de) | Medikamente. | |
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
CA2123909A1 (en) | New combination of formoterol and budesonide | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
HU9202808D0 (en) | Improvement of down-regulqtion of autoimmunic diseases by means of oral dosing of autoantigenes | |
DE69200711D1 (de) | Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung. | |
MY111155A (en) | Medicaments | |
JPS6438027A (en) | Remedy for cancer | |
RU93003454A (ru) | Лекарственный препарат |